💡 Published in @bmj.com Open: the maternal protocol for #PregInPoxVac, the first trial testing maternal MVA-BN mpox vaccination in 362 pregnant individuals in the DRC. Penta leads the social science work building vaccine confidence in mpox-endemic communities. 🔗 bmjopen.bmj.com/content/16/7...

Calling all early-mid career clinical trialists with little to no stats background! ADVANCE-ID Network is hosting a FREE statistical seminar series to bridge the gap between complex theory and real-world research. Don't let stats be a barrier. Kicks off Aug 31! Details👇

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID)@advance-id.bsky.social · 2mo ago

Demystify clinical trial design & enhance your research toolkit!📊✨ Join our statistical seminars supported by @advance-id.bsky.social & @who.int Explore clinical trial theory & real-life examples with global experts. Master the numbers in the mission against disease here: ad-id.co/stats

Demystify clinical trial design & enhance your research toolkit!📊✨ Join our statistical seminars supported by @advance-id.bsky.social & @who.int Explore clinical trial theory & real-life examples with global experts. Master the numbers in the mission against disease here: ad-id.co/stats

Additional findings from the D3 (PENTA-21) trial show DTG-based regimens remain a strong, reliable option for children. Data shows simplified treatment works well even with prior drug resistance, marking a meaningful step forward in improving care standards for children living with #HIV.

New D3 (PENTA-21) findings add reassurance about simplified HIV treatment for children | Penta

New results from the D3 (PENTA-21) trial, sponsored by Fondazione Penta ETS, add to the evidence that dolutegravir-based treatment remains a strong option for children living with HIV, even when the H...

penta-id.org

How can children with community-acquired pneumonia return home sooner while continuing to receive safe, effective treatment? In the #PediCAP podcast, 3 trial staff discuss the trial’s innovative ROCI design, its findings & what they mean for children, families & healthcare professionals. 🎧 Listen

PediCAP trial: Optimising treatment for children with severe community-acquired pneumonia

Children with community-acquired pneumonia are usually treated with an injectable antibiotic for five days. This often means staying in hospital for the full treatment period, even when they are well

soundcloud.com

What does it take for parents to be partners in newborn health research? 👶🌍 Across Uganda, Tanzania & beyond, #SNIP-AFRICA has been listening to parents, midwives & health workers about parent support groups in neonatal sepsis trials.

⏰ Registration is still open for our PentaTraining Fungal Infections in Paediatrics course! Don't miss your chance to join this highly interactive e course delivered by international experts. Reserve your place today penta-id.org/fungal-infec...

Check out the SUPPORT e-poster presented at the International Workshop on Pediatrics & HIV 2026! Post-discharge mortality among children living with #HIV is a critical challenge in Africa. Focus is placed on inpatient survival but the transition from hospital to home remains fragile.

🧵 1/5 New PediCAP just results published in @thelancet.com suggest children with severe pneumonia can safely switch from injectable to oral antibiotics once they begin to recover and go home sooner! Read publication www.thelancet.com/journals/lan...

We've officially signed an MoU with @medicinespatentpool.org to ensure children in LMICs have equitable access to the priority health technologies they need and deserve! #AIDS2026

Penta and Medicines Patent Pool strengthen collaboration to advance equitable access to paediatric health technologies | Penta

Fondazione Penta ETS and the Medicines Patent Pool (MPP) have signed a Memorandum of Understanding (MoU), formalising a strategic collaboration to support the development and equitable access of prior...

penta-id.org

Medicines Patent Pool@medicinespatentpool.org · 3mo ago

@medicinespatentpool.org and @pentafoundation.bsky.social are pleased to announce the signing of a MoU to strengthen collaboration in support of equitable #access to priority health technologies for #children in LMICs. 👉 medicinespatentpool.org/partners/who... #AIDS2026

The PregInPoxVac trial protocol is published in Vaccine! This DRC trial evaluates the safety & immune response of the MVA-BN vaccine in infants & toddlers. It also studies community perceptions to build trusted, community-centred campaigns.

Protocol paper published for the PregInPoxVac mpox vaccine trial | Penta

A protocol paper describing part of the PregInPoxVac study has been published in Vaccine. The paper outlines the design of a phase 3 trial evaluating the safety and immunogenicity of two-dose Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine regimens in children aged 4 to under 24 months living in the Democratic Republic of the Congo (DRC).

penta-id.org

New children’s storybook from Chiva! Grace, Gigi and HIV 📖 is a gentle storybook & explanation cards designed to help children understand #HIV & talk about it with confidence. Read online: www.chiva.org.uk/families/supporting-a-young-person/talking-hiv/ Request free copies: message@chiva.org.uk

Join Penta ID Network members & leading experts, in Rio de Janeiro 🇧🇷 on 24–25 July at the #PediatricsHIV Workshop ahead of #AIDS2026! A must attend event for those working to advance care, research & outcomes for children & adolescents living with HIV. Register 👉 https://bit.ly/4eYVYol

A breakthrough in a lab doesn't save a child's life. The clinician who has the knowledge and tools to implement it does! Read to learn more about PentaTr@ining has been bridging paediatric infectious disease research & real-world practice. #PentaTraining #PentaAnnualReport2025

Two decades of impact: translating research into life-saving care | Penta

"In 2025, PentaTr@ining marked an important milestone: twenty years of turning paediatric infectious disease research into tangible improvements in maternal and child healthcare. What began as a Europ...

penta-id.org

🔴 WEBINAR ALERT! 23 Jul, 15:00-16:00 CEST Join NeoNET Africa & NeoIPC: “From detection to prevention: surveillance and IPC in neonatal sepsis”. Including a presentation of the free online #NeoIPC #Surveillance Toolkit for neonatal units. ✍ Learn more and register: neoipc.org/join-the-neo...

Join the NeoNET Africa webinar: "From detection to prevention: surveillance and IPC in neonatal sepsis" - NEOIPC PROJECT

NeoIPC invites you to join the next session in the NeoNET Africa online Seminar Series 2026, taking place on 23 July 2026, 15:00–16:00 CEST/SAST. NeoNET Africa is a network dedicated to tackling the p...

neoipc.org

#NeoSep1 has officially expanded to Pakistan! 🇵🇰 We are proud to be a partner in this innovative clinical trial, improving antibiotic treatment options for newborns with sepsis. @gardp.bsky.social @innovative-ctu.bsky.social @citystgeorges.bsky.social

Global Antibiotic R&D Partnership (GARDP)@gardp.bsky.social · 3mo ago

Every year, millions of newborns develop sepsis. For many, the antibiotics available are no longer effective. We're proud to announce the launch of the #NeoSep1 clinical trial at Aga Khan University Hospital in Pakistan, helping advance better treatment options for newborns with sepsis. #AMR

Penta stands with the people of Venezuela, including our Network members, PentaTr@ining delegates, partners and collaborators, as well as all healthcare professionals working tirelessly to support affected communities and sustain essential health services for mothers and children.

Interested in joining a project aiming at improving the life of children living with #HIV? The SUPPORT project has one post-doctoral position on biostatistics currently open at Makerere University Uganda🇺🇬! More details👇 euraxess.ec.europa.eu/jobs/446832 More about SUPPORT 👉 www.supportproject.eu

🎉 𝗢𝘂𝗿 𝟮𝟬𝟮𝟱 𝗔𝗻𝗻𝘂𝗮𝗹 𝗥𝗲𝗽𝗼𝗿𝘁 𝗶𝘀 𝗵𝗲𝗿𝗲! Thanks to our members and collaborators, last year we expanded our research, strengthened the Network and strengthened scientific partnerships. 2025 brought us closer to improving health outcomes for children & pregnant people worldwide. 📖: lnkd.in/dCajFJra

🌍 NeoSep1 is expanding to Asia! This landmark clinical trial, already running in South Africa, Kenya & Ghana, is now enrolling in India, working to find affordable treatments for drug-resistant neonatal sepsis.

Global Antibiotic R&D Partnership (GARDP)@gardp.bsky.social · 4mo ago

🚨 This is BIG! 👶JIPMER in India enrolled the first baby in Asia into the NeoSep1 trial. Since then, babies have been enrolled at the Rohtak site, with Mumbai next. 🧪 Led by GARDP and partners, NeoSep1 is one of the most ambitious clinical trials ever undertaken for neonatal sepsis.

New findings from a PediCAP analysis found no difference in gut microbiota effects between oral step-down antibiotics & IV treatment. The gut also showed signs of recovery over time! A hopeful result for children with pneumonia. https://www.nature.com/articles/s44259-026-00216-5

New PIPELINE data from 1800 European parents & clinicians finds maternal #RSV vaccination ranks highest yet 1 in 5 parents haven’t heard of RSV & many mix up vaccine vs antibody options. Better education & stronger clinician–family conversations are vital to protect infants. https://bit.ly/3RLxRjX

New ODYSSEY results show that dolutegravir cut treatment failure in children with HIV (19% vs 34% at 240 weeks) and showed no new safety problems. A hopeful step for stronger, simpler care for kids worldwide! More 👉 https://academic.oup.com/ofid/article/13/5/ofag266/8669861

Happening now at #ESPID! Join us in Room Argento to learn more about PIPELINE and Be Ready projects!

We're at ESPID! Are you? Join the SLIPE-Penta session in Sala Europa & visit our stand in the Exhibition Hall!

🚨 PIs & site managers (NL 🇳🇱 IE 🇮🇪 HR 🇭🇷 NO 🇳🇴 LT 🇱🇹 LV 🇱🇻 EE 🇪🇪) The READI Project is mapping clinical trial site capabilities across Europe to improve inclusion of underrepresented populations! ⏱ 12-15 min survey 🔐 Confidential & aggregated 👉 Learn more & complete survey: ihi-readi.org/news/readi-c...

Tomorrow is #KangarooCareAwarenessDay & #NeoIPC is proud to share 2 new stories in our “NICU Journeys” series, featuring interviews with Emma & Luken's parents 💜🦘 Their experiences highlight the importance of #KangarooCare, family involvement and #IPC in the #NICU. 🎥 Watch here ➡️ lnkd.in/d-sstx5y

📢 Calling all all researchers and professionals in pharmacology! Join the 2026 #AntiviralPK workshop in Montreal, Canada (2-3 Sept) & connect with leading experts advancing the future of antiviral therapeutics. Abstract submission is open until 12 June! academicmedicaleducation.com/programs/27t...

Why are mortality rates of children living with #HIV so high? In her work in the SUPPORT project, Nsofwa Sukwa is exploring the link between #CMV viral loads and mortality rates in these children. Check out her insights in her latest blog here bit.ly/4nk1O6t

Did you know that RSV infection is dangerous for children under 5 with HIV? For these children, RSV can turn into a life-threatening condition. Read this blog by SUPPORT fellow Cheelo Mwiinga with pointers for families & caregivers of children living with HIV. supportproject.eu/understandin...